LOWPOC
CVE-2006-4676
NVD-CWE-OtherPublished: September 11, 2006· Updated: Jun 16, 2026
1.2
CVSS v3.1
Official Description
TIBCO RendezVous 7.4.11 and earlier logs base64-encoded usernames and passwords in rvrd.db, which allows local users to obtain sensitive information by decoding the log file.
Technical Analysis
CVE-2006-4676 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
A proof-of-concept (PoC) exploit exists for CVE-2006-4676. While not yet confirmed in active campaigns, the availability of PoC code increases exploitation risk substantially.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorLocal
Attack ComplexityHigh
Privileges Req.
User Interaction
Scope
Impact
ConfidentialityP
IntegrityNone
AvailabilityNone
AV:L/AC:H/Au:N/C:P/I:N/A:N
Affected Vendors & Products
tibco1 product(s)
rendezvous
Source: NVD CPE · 1 total CPE entries
Exploit & PoC Resources
POC AVAILABLEProof-of-concept code exists
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
Official Patches & Advisories
All References (8)
→
http://secunia.com/advisories/21748Vendor Advisory
→
http://secunia.com/advisories/21748Vendor Advisory
Quick Facts
CVE IDCVE-2006-4676
CVSS Score1.2 / 10
SeverityLOW
WeaknessNVD-CWE-Other
CISA KEVNo
ExploitPOC
Affected1 vendor(s)
PublishedSep 11, 2006
Related CVEs (NVD-CWE-Other)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2006-4676 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.